'Hallucinogenic drugs and central transmitter substances'.
D000661:Amphetamine / Q000494:pharmacology; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D013759:Dronabinol / Q000494:pharmacology; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008635:Mescaline / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010276:Parasympatholytics / Q000494:pharmacology; D010622:Phencyclidine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects*
D001679:Biogenic Amines; D006213:Hallucinogens; D010276:Parasympatholytics; D012701:Serotonin; D013759:Dronabinol; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D010622:Phencyclidine; D008635:Mescaline; D004298:Dopamine; D009638:Norepinephrine